Efficacy and safety of LongShengZhi capsule on functional recovery after acute ischemic stroke (LONGAN): Protocol and statistical analysis plan for a randomized, double-blind, placebo-controlled trial

Background: Due to limited time windows and technical requirements, only a small percentage of patients can receive reperfusion therapy for acute ischemic stroke (AIS). Previous studies have shown that LongShengZhi (LSZ) capsule can improve neurological outcomes in patients after AIS, yet those resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dandan, Li, Tingting, Wang, Anxin, Feng, Luda, Lai, Xinxing, Cao, Kegang, Zhou, Li, Yang, Baolin, Cui, Fangyuan, Li, Qingbin, Dou, Jinjuan, Qi, Baoyun, Zhang, Chi, Gao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448855/
https://www.ncbi.nlm.nih.gov/pubmed/36091794
http://dx.doi.org/10.3389/fphar.2022.916421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448855/
https://www.ncbi.nlm.nih.gov/pubmed/36091794
http://dx.doi.org/10.3389/fphar.2022.916421

Ejemplares similares